Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Broadgate Consultants was a specialized strategic communications and investor relations firm based in New York. The firm focused on providing high-level advisory services to companies within the healthcare, life sciences, and financial services sectors. Their core offerings included corporate positioning, financial media relations, and transaction support for complex events such as IPOs and M&A. Broadgate was well-regarded for its deep industry knowledge and its ability to manage the reputations of emerging biotech and established pharmaceutical companies. In 2010, the firm was acquired by MSLGROUP, a global communications firm under the Publicis Groupe umbrella. This acquisition was intended to strengthen MSLGROUP's financial communications and healthcare practices in the United States. Following the merger, Broadgate's team and expertise were integrated into the MSLGROUP network.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Broadgate Consultants.